Director Laura Hamill files initial Form 3 for FATE Therapeutics (FATE)
Rhea-AI Filing Summary
FATE Therapeutics Inc. director Laura Hamill has filed an initial Form 3, which is a required statement of beneficial ownership for insiders. The data provided shows no reported transactions or derivative positions, indicating this is an administrative disclosure of her insider status rather than a trading event.
Positive
- None.
Negative
- None.
Key Terms
Form 3, beneficial ownership, reporting person
3 terms
Form 3 regulatory
"Laura Hamill has filed an initial Form 3, which is a required statement of beneficial ownership"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership financial
"Form 3, which is a required statement of beneficial ownership for insiders"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
reporting person regulatory
"The reporting person is Laura Hamill, identified as a director of FATE Therapeutics Inc."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Laura Hamill’s Form 3 filing for FATE Therapeutics (FATE) indicate?
Laura Hamill’s Form 3 indicates she is an insider of FATE Therapeutics as a director. It is an initial statement of beneficial ownership and, in this data, serves as an administrative disclosure rather than reflecting any recent trading activity.
What is the significance of transaction counts being zero in FATE’s Form 3?
All transaction counts being zero means the filing records no recent trades, gifts, exercises, or restructurings. It functions purely as an initial ownership statement, confirming insider status without signaling any change in position through market or non-market transactions.
Who is the reporting person on this FATE Therapeutics Form 3 filing?
The reporting person is Laura Hamill, identified as a director of FATE Therapeutics Inc. Her role classifies her as an insider under SEC rules, requiring disclosure of beneficial ownership through Form 3 and subsequent updates if she later reports transactions.
Does the Form 3 for FATE mention any derivative securities for Laura Hamill?
No, the derivative summary section for this Form 3 is empty, and the derivative transaction count is zero. This indicates that, in the data provided, there are no option, warrant, or other derivative positions reported for Laura Hamill at this time.